What is LOPJLB’s current signal on IMDX?

LOPJLB’s latest quantitative signal on Insight Molecular Diagnostics Inc. (IMDX) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is IMDX in?

Insight Molecular Diagnostics Inc. (IMDX) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Insight Molecular Diagnostics Inc. (IMDX) do?

OncoCyte Corporation functions as a molecular diagnostics firm specializing in the research, development, and market introduction of distinctive, laboratory-developed tests aimed at cancer identification. Its operations span both the United States and international territories. The company's key offerings include DetermaRx, a molecular diagnostic tool tailored for detecting early-stage adenocar…

Where is Insight Molecular Diagnostics Inc. based / listed?

Insight Molecular Diagnostics Inc. is based in US, listed on NASDAQ.

Insight Molecular Diagnostics Inc. (IMDX)

COMPARE

Healthcare · Medical - Diagnostics & Research · NASDAQ · US

$3.37+2.74%Close

SELLCRISIS · day 10

[SCORES & PROFILE]

FUND: 0
VALUE: 12
GROWTH: 0
GARP: 3
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC163.1%

REV YoY-

ROE271.8%

EPS YoY-

ROA-167.6%

GROSS

-2559

NET

-2956

[VALUATION]

P/E TTM-2.22

P/E FWD-

SECTOR PE20.47

INDUSTRY PE31.73

P/B-5.83

P/FCF-

EV/EBITDA-2.01

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E-

ALTMAN Z-

CURR RATIO2.00

ND/EBITDA-

BETA1.80

Insight Molecular Diagnostics Inc. (IMDX)

Key stats

Industry peers

Prediction markets

FUNDAMENTALS

Company news